January 15, 2026
2025 Year in Review: China Medical Robotics
Eight NMPA Class III approvals, $370M+ in headline funding, and Chinese surgical robots shipping to nearly 40 countries — a review of 2025's structural shift.
read more ›News
December 29, 2025
Edge Medical Lists on Hong Kong Stock Exchange in December 2025
Edge Medical Robotics listed on the Hong Kong Stock Exchange in late December 2025, trading under 2675.HK after a confidential IPO filing process began in August.
read more ›August 30, 2025
Surgerii Lands CE Mark for SHURUI Single-Port Robot, Closes $100M Series D
Surgerii's SHURUI single-port robot received CE certification under EU MDR in August 2025, followed by a $100M Series D led by Loyal Valley Capital for global expansion.
read more ›July 9, 2025
NMPA Issues 10 Measures Supporting High-End Medical Devices, Names Surgical Robots a Priority
NMPA Announcement No. 63, July 2025: 10 measures to support high-end medical devices, naming surgical and rehabilitation robots as priority categories.
read more ›July 3, 2025
Toumai Completes LEO Satellite Telesurgery in July 2025, a Claimed Global First
MicroPort MedBot's Toumai completed liver tumor resections via LEO satellite, Xiong'an to Beijing, July 2–3, 2025, with one-way latency under 60 ms per the company.
read more ›March 21, 2025
ETcath Wins NMPA Approval as China's First Fully Domestic Coronary Interventional Robot
WeMed Medical's ETcath received NMPA approval March 21, 2025, becoming China's first fully domestically developed robot for percutaneous coronary intervention.
read more ›